Jack Higgins - Dec 1, 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Signature
/s/ Sandra Stoneman, Attorney-in-fact
Stock symbol
IMNM
Transactions as of
Dec 1, 2023
Transactions value $
$0
Form type
4
Date filed
12/5/2023, 09:08 PM
Previous filing
Oct 12, 2023
Next filing
Aug 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +200K $0.00 200K Dec 1, 2023 Common Stock 200K $7.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 1, 2023, Dr. Higgins was granted an option to purchase 200,000 shares of common stock. The option vests (i) with respect to 100,000 shares, 25% of such shares subject to the option, vest on November 17, 2024, and the remaining shares will vest monthly thereafter over three years, and (ii) with respect to the remaining 100,000 shares, which vesting shall commence as of the date a certain condition set forth in Dr. Higgins' Amended and Restated Offer Letter dated November 30, 2023, is satisfied, 25% of the shares subject to the option will vest 1 year from the completion of that certain condition, and the remaining shares will vest monthly thereafter over three years.